氨曲南治疗老年患者中重度下呼吸道感染的临床分析  

Clinical analysis of aztreonam in the treatment of elderly patients with moderate and severe lower respiratory tract infections

作　　者：时从才 Shi Congcai(Cancer Hospital of Haian County,Nantong City,Jiangsu Province 226681)

机构地区：[1]江苏省南通市海安县肿瘤医院,226681

出　　处：《中国社区医师》2016年第4期39-40,共2页Chinese Community Doctors

摘　　要：目的:探讨氨曲南治疗老年患者中重度下呼吸道感染的临床效果。方法:收治老年中重度下呼吸道感染患者120例,随机平分成两组,观察组给予氨曲南进行治疗,对照组给予头孢塞肟钠进行治疗。比较两种患者的细菌消除率、不良反应率和肺功能改善情况。结果:观察组治疗总有效率、细菌消除率均高于对照组,不良反应率低于对照组;观察组的FEV1、FVC及PEF 3项肺功能改善程度明显优于对照组,差异具有统计学意义(P<0.05)。结论:氨曲南治疗老年患者中重度下呼吸道感染的临床效果显著。Objective:To investigate the clinical effect of aztreonam in the treatment of elderly patients with moderate and severe lower respiratory tract infections.Methods:120 elderly patients with moderate and severe lower respiratory tract infections were selected.They were randomly divided into the two groups on average.Patients in the observation group received the treatment of aztreonam,while patients in the control group were treated with cefotaxime sodium.We compared bacterial elimination rate,adverse reaction rate and pulmonary function improvement of the patients in the two groups.Results:The total effective rate and the elimination rate of bacteria in the observation group were higher than those of the control group;the adverse reaction rate was lower than that of the control group;the improvement of pulmonary function of PEF,FVC and FEV1 in the observation group were significantly better than those in the control group;the differences were statistically significant(P<0.05).Conclusion:The clinical efficacy of aztreonam in the treatment of elderly patients with moderate and severe lower respiratory tract infections is significant.

关 键 词：氨曲南 老年患者 中重度下呼吸道感染 

分 类 号：R56[医药卫生—呼吸系统]